Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials.
Flynn
Harry W
HW
Bascom Palmer Eye Institute, Miami, FL 33136, USA. hflynn@med.miami.edu
Scott
Ingrid U
IU
D002986:Clinical Trials as Topic; D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D012170:Retinal Vein Occlusion / Q000150:complications / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide